CANADIAN NATIONAL STOCK EXCHANGE · BHST
+0.74% · +$0.0150 · Vol 9.2K
Market closed · last close 4:00 PM ET · price as of 16:00:00 ET
BioHarvest Sciences Inc

BioHarvest Sciences Inc

Consumer products
$2.06
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
Sentiment absence reason unknown
BHST
BioHarvest Sciences Inc
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
SELL BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

39/ 100
Veridion Score
SELL BIAS · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is BHST moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading BHST catalysts
About BioHarvest Sciences Inc
Consumer products
Listed since
2019
Employees
89
Country
CA

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$2.04
Day high
$2.17
Day low
$2.03
Previous close
$2.04
52W high
$12.65
-83.75% from high
52W low
$1.92
1% of range
Market cap
$46.6M
EPS
$-1.1911
Beta
0.35
Shares out
22.7M
Volume
9.2K
0.13× rel vol
Avg volume
72.7K
VWAP
$2.09
Price history computed in-house
1W
-5.30%
1M
+7.03%
3M
-47.44%
1Y
-76.46%
YTD
-60.40%
SMA 50 $2.56 · below
SMA 200 $4.32 · below
52W position 1%

BHST overview

Veridion Score
39
Registered · 2026-08-21
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around BHST.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading BHST Form 4 filings
Public disclosures

Congress activity in BHST

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for BHST in the cached public ledger.

Federal contracts

BHST contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BHST in this window.
Lobbying spend

BHST lobbying filings, year to date.

Registered lobbying filings matched to BioHarvest Sciences Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BHST in this window.
Loading news for BHST
Analyst ratings
Sovereign unlock shows live analyst consensus for BHST.
Options
Sovereign unlock shows live options positioning for BHST.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.